Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Tests washed microbiota transplantation for diabetic stomach and gut movement problems

Tests washed gut bacteria transplant in adults with diabetes-related digestive movement disorders.

Plain-language title generated from the registry record
Registry title: Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study

Key facts

Where
Nanjing, ChinaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes and a diabetic stomach and bowel movement disorder, to test washed microbiota transplantation.

Age
18 Years to 75 Years
Sex
All sexes can join.
Disease stage
Type 2 diabetes with a diabetic gastrointestinal motility disorder. HbA1c below 11.0% (97 mmol/mol).
Earlier treatment
People using antibiotics cannot join.
Biomarker or test result
Glycated hemoglobin (HbA1c) < 11.0% (97 mmol/mol).

Main reasons for not taking part

  • Insulin dependent diabetes
  • Active infection, antibiotic use, inflammatory bowel disease, irritable bowel syndrome or other severe gut disease
  • Severe diabetic complications
  • Thyroid disease, cancer, severe cognitive impairment or mental illness
  • Alcohol or substance abuse, pregnancy or breastfeeding

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06340828, who can take part

Where in China

  • The Second Affiliated Hospital of Nanjing Medical UniversityNanjing, ChinaContact: Dafa Ding, ProfessorNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
The Second Hospital of Nanjing Medical University
Trial code
NCT06340828
Record updated
3 April 2024
Original description
The goal of this clinical trial is to learn about effectiveness and safety of washing microbiota transplantation in diabetic gastrointestinal motility disorders participant population. The main questions it aims to answer are:Read full original descriptionShow less

Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study

The goal of this clinical trial is to learn about effectiveness and safety of washing microbiota transplantation in diabetic gastrointestinal motility disorders participant population. The main questions it aims to answer are:

* The risk factors of diabetic gastrointestinal motility disorders in routine clinical data or biochemical tests. * The composition of gut microbiota in diabetic gastrointestinal motility disorders patients and potential pathogenic bacteria. * The efficacy of washing microbiota transplantation in the clinical treatment of diabetic gastrointestinal motility disorders patients and potential factors that may influence treatment outcomes. * The potential mechanisms of washing microbiota transplantation in treating diabetic gastrointestinal motility disorders patients.

Participants will be collected fasting venous blood and random stool samples before treatment and at week 12 post-treatment, conducting scale assessments before treatment and at weeks 1, 4, and 12 post-treatment.

Inclusion: Clinical diagnosis of type 2 diabetes and diabetic gastrointestinal motility disorder; Glycated hemoglobin (HbA1c) < 11.0%.

Exclusion: Insulin dependent diabetes; Active infections, antibiotics-using, inflammatory bowel disease, irritable bowel syndrome, or other severe gastrointestinal organic disease; Thyroid disease, malignancies, severe cognitive impairment and mental disease; Severe diabetic complications; Alcohol or substance abuse; Pregnancy or lactation.

ClinicalTrials.gov NCT06340828